Ping Cai
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Toxicology top 5%
Papers in
- Oncology 13
- Peptidase Inhibition and Analysis 10
- Co-authors
- Andrew M. Rauth (15 shared papers)Xiao Yu Wu (15 shared papers)Yongqiang Zhang (2 shared papers)Guanghui Cheng (1 shared paper)Yuanyuan Zhang (1 shared paper)Mark Ruppen (8 shared papers)Chunsheng He (4 shared papers)Jason Li (4 shared papers)
- Journals
- Journal of Natural Products (5 papers)Cancer Research (4 papers)Journal of Controlled Release (3 papers)Molecular Pharmaceutics (3 papers)Drug Delivery and Translational Research (3 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Ping Cai
57 papers receiving 1.4k citations
Ping Cai's Hit Papers
Peers
Comparison fields: 5 of 117
- Biomaterials 360
- Toxicology 48
- Biochemistry 76
- Pharmacology 184
- Biotechnology 90
Countries citing papers authored by Ping Cai
This map shows the geographic impact of Ping Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Cai more than expected).
Fields of papers citing papers by Ping Cai
This network shows the impact of papers produced by Ping Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Cai. The network helps show where Ping Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Brief Review of Phenolic Compounds Identified from Plants: Their Extraction, Analysis, and Biological Activity Hit paper breakdown → | 2022 | 208 |
| 2 | 1993 | 84 | |
| 3 | 2016 | 81 | |
| 4 | 2016 | 75 | |
| 5 | 2019 | 72 | |
| 6 | 2014 | 66 | |
| 7 | 2022 | 64 | |
| 8 | 2005 | 64 | |
| 9 | 2015 | 62 | |
| 10 | 2005 | 58 | |
| 11 | 2005 | 55 | |
| 12 | 2017 | 54 | |
| 13 | 2007 | 35 | |
| 14 | 2006 | 35 | |
| 15 | 1999 | 32 | |
| 16 | 2005 | 31 | |
| 17 | 1995 | 29 | |
| 18 | 2007 | 29 | |
| 19 | 2013 | 26 | |
| 20 | 1998 | 26 |
About Ping Cai
Ping Cai is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Peptidase Inhibition and Analysis (10 papers), Nanoparticle-Based Drug Delivery (8 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Microbial Natural Products and Biosynthesis (7 papers), Prostate Cancer Treatment and Research (7 papers), Synthetic Organic Chemistry Methods (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Biomaterials (360 citations), Toxicology (48 citations), Biochemistry (76 citations), Pharmacology (184 citations) and Biotechnology (90 citations). Ping Cai has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Andrew M. Rauth, Xiao Yu Wu, Yongqiang Zhang, Guanghui Cheng, Yuanyuan Zhang, Mark Ruppen, Chunsheng He, Jason Li, Tian Zhang and Preethy Prasad. Their work appears in journals such as Journal of Natural Products, Cancer Research, Journal of Controlled Release, Molecular Pharmaceutics and Drug Delivery and Translational Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.